5.14
price up icon0.00%   0.00
after-market 시간 외 거래: 5.14
loading
전일 마감가:
$5.14
열려 있는:
$5.12
하루 거래량:
167.76K
Relative Volume:
0.20
시가총액:
$232.29M
수익:
-
순이익/손실:
$-32.74M
주가수익비율:
-6.2683
EPS:
-0.82
순현금흐름:
$-24.89M
1주 성능:
-0.39%
1개월 성능:
+46.02%
6개월 성능:
-60.91%
1년 성능:
-50.86%
1일 변동 폭
Value
$5.12
$5.15
1주일 범위
Value
$5.08
$5.20
52주 변동 폭
Value
$3.18
$16.94

Third Harmonic Bio Inc Stock (THRD) Company Profile

Name
명칭
Third Harmonic Bio Inc
Name
전화
(209) 727-2457
Name
주소
1700 MONTGOMERY STREET, SAN FRANCISCO
Name
직원
53
Name
트위터
Name
다음 수익 날짜
2025-03-26
Name
최신 SEC 제출 서류
Name
THRD's Discussions on Twitter

THRD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
THRD
Third Harmonic Bio Inc
5.14 232.29M 0 -32.74M -24.89M -0.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Third Harmonic Bio Inc Stock (THRD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-28 다운그레이드 Stifel Buy → Hold
2025-02-12 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2025-02-11 다운그레이드 Raymond James Outperform → Mkt Perform
2024-08-09 업그레이드 Morgan Stanley Equal-Weight → Overweight
2024-06-18 개시 Stifel Buy
2024-06-07 개시 Raymond James Outperform
2022-12-16 다운그레이드 Jefferies Buy → Hold
2022-12-15 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2022-10-10 개시 Cowen Outperform
2022-10-10 개시 Jefferies Buy
2022-10-10 개시 Morgan Stanley Overweight
모두보기

Third Harmonic Bio Inc 주식(THRD)의 최신 뉴스

pulisher
Apr 23, 2025

Third Harmonic Bio CSO steps down, enters separation agreement - Investing.com Australia

Apr 23, 2025
pulisher
Apr 23, 2025

Third Harmonic Bio’s CSO Christopher Dinsmore Steps Down - MSN

Apr 23, 2025
pulisher
Apr 22, 2025

Third Harmonic Bio CSO steps down, enters separation agreement By Investing.com - Investing.com South Africa

Apr 22, 2025
pulisher
Apr 18, 2025

New fund Alis offers struggling biotechs an off-ramp: Finance Report - BioCentury

Apr 18, 2025
pulisher
Apr 17, 2025

Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com

Apr 17, 2025
pulisher
Apr 16, 2025

SF biotech company, once worth nearly $1 billion, plans to shut down - SFGATE

Apr 16, 2025
pulisher
Apr 16, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Apr 16, 2025
pulisher
Apr 16, 2025

Third Harmonic Bio (THRD) Plans Liquidation; Significant Search Surge in Biotech Sector | ARTL Stock News - GuruFocus

Apr 16, 2025
pulisher
Apr 15, 2025

Third Harmonic Bio (THRD) Seeks Stockholder Approval for Liquida - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Third Harmonic Bio plans to liquidate the company, sell urticaria treatment - MSN

Apr 15, 2025
pulisher
Apr 15, 2025

Third Harmonic Bio, Inc. Liquidation and Shareholder Distribution: Analyst Maintains Hold Rating Amid Strategic Uncertainties - TipRanks

Apr 15, 2025
pulisher
Apr 15, 2025

Third Harmonic's shutdown, Coherus and Xoma drug sales connectedBizwomen - The Business Journals

Apr 15, 2025
pulisher
Apr 15, 2025

Third Harmonic Bio leaps as it reveals liquidation plan - The Pharma Letter

Apr 15, 2025
pulisher
Apr 15, 2025

Big moves by small biotechs signal potential shift for investorsSan Francisco Business Times - The Business Journals

Apr 15, 2025
pulisher
Apr 15, 2025

Top 3 Health Care Stocks You May Want To Dump This Quarter - Benzinga

Apr 15, 2025
pulisher
Apr 15, 2025

Fierce Biotech Layoff Tracker 2025: Mural lays off 90%; Pfizer sells site, cuts staff - Fierce Biotech

Apr 15, 2025
pulisher
Apr 15, 2025

Third Harmonic Bio Announces Liquidation Plan: Stock Skyrockets 39% Pre-Market, But Retail’s Shattered - MSN

Apr 15, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio plans liquidation and asset sale By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

$26bn Brighton Jones hires new CFO - Citywire

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio, Apple, Dell And Other Big Stocks Moving Higher In Monday's Pre-Market Session (CORRECTED) - Benzinga

Apr 14, 2025
pulisher
Apr 14, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic outlines plans for dissolution - BioPharma Dive

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio sees initial distribution of $5.13-$5.33 from liquidation - TipRanks

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio stock holds as liquidation plan unveiled By Investing.com - Investing.com Canada

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio Stock Is Up 40% Monday: What's Happening?Third Harmonic Bio (NASDAQ:THRD) - Benzinga

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Announces Liquidation And Cash Return, Stock Jumps - Nasdaq

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic to shutter; Future Pak once again targets Theratechnologies - Endpoints News

Apr 14, 2025
pulisher
Apr 14, 2025

THRD’s Ambitious Moves: From Trials to Strategies? - timothysykes.com

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio Plans Liquidation With Lucrative Payouts - Finimize

Apr 14, 2025
pulisher
Apr 14, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio announces plan of liquidation and dissolution - TipRanks

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Seeks to Liquidate, Dissolve Company - marketscreener.com

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio Announces Plan Of Liquidation And Dissolution - marketscreener.com

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio Announces Plan of Liquidation and Dissolution - The Manila Times

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio plans liquidation and asset sale - Investing.com Australia

Apr 14, 2025
pulisher
Apr 14, 2025

Third Harmonic Bio to Return $255M to Shareholders in Major Cash Distribution - Stock Titan

Apr 14, 2025
pulisher
Apr 11, 2025

Layoff Tracker: Opthea Slashes 65% of Staff, Pfizer Cuts 56 - BioSpace

Apr 11, 2025
pulisher
Apr 07, 2025

Third Harmonic stock rating cut by Raymond James - MSN

Apr 07, 2025
pulisher
Mar 31, 2025

Third Harmonic Bio initiates process to identify opportunities to maximize value - TipRanks

Mar 31, 2025
pulisher
Mar 29, 2025

Hold Rating for Third Harmonic Bio, Inc. Amid Strategic Exploration and Cautious Development Approach - TipRanks

Mar 29, 2025
pulisher
Mar 29, 2025

Stifel Downgrades Third Harmonic Bio (THRD) - MSN

Mar 29, 2025
pulisher
Mar 28, 2025

Stifel Nicolaus Downgrades Third Harmonic Bio to Neutral From Buy, Adjusts Price Target to $5 From $23 - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

Third Harmonic Bio Reports 2024 Financial Results and Strategic Plans - TipRanks

Mar 28, 2025
pulisher
Mar 27, 2025

Third Harmonic Bio reports FY24 EPS ($1.09) vs. (78c) last year - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Stifel cuts Third Harmonic stock rating to hold, slashes target to $5 - Investing.com

Mar 27, 2025

Third Harmonic Bio Inc (THRD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
자본화:     |  볼륨(24시간):